In both EAC and ESCC, the suppression of NRF2 expression markedly diminishes ferroptosis markers SLC7A11/GPX4 and facilitates ferroptosis, which finally enhances patients' resistance to CRT and elevates the survival rate of EC.31 The gene discussed is NFE2L2; the disease is esophageal squamous cell carcinoma.